Characterization of a xenoantiserum produced against three molar KCl-solubilized antigens obtained from a non-T, non-B (pre-B) acute lymphoblastic leukemia cell line.
D000042:Absorption; D000818:Animals; D000918:Antibody Specificity; D000941:Antigens; D001402:B-Lymphocytes / Q000276:immunology*; D002460:Cell Line; D006801:Humans; D007106:Immune Sera / Q000276:immunology* / Q000494:pharmacology; D007945:Leukemia, Lymphoid / Q000276:immunology*; D010641:Phenotype; D011189:Potassium Chloride / Q000494:pharmacology; D011817:Rabbits; D012995:Solubility; D013601:T-Lymphocytes / Q000276:immunology*; D014183:Transplantation, Heterologous
D000941:Antigens; D007106:Immune Sera; D011189:Potassium Chloride